Latest Growth Initiatives News

Champion Iron Limited reported record quarterly sales and strong earnings in FY2025 Q4, while advancing its DRPF project on schedule and declaring its eighth consecutive dividend.

Amaero Ltd updates its financial outlook, targeting positive EBITDA by FY2027 and reaffirming a A$72 million capital investment plan despite delays in US Department of Defense contracts.

ALS Limited has announced a fully underwritten A$350 million equity placement to fund major upgrades to its global laboratory network and support future growth initiatives, aiming for mid single-digit EPS accretion by FY25 pro forma.

Bass Oil Limited reported steady April production and a strategic acquisition of the Vanessa gas field, positioning itself for future gas market entry.

Experience Co Limited has announced a significant on-market share buy-back of up to 10% of its issued capital, signaling renewed confidence in its financial health and future prospects.

Elders Limited has reported a robust 67% increase in underlying EBIT for the half-year ending March 2025, driven by livestock market recovery and real estate growth, alongside five new acquisitions and ongoing transformation initiatives.

Genesis Minerals has secured the Laverton Gold Project from Focus Minerals for A$250 million, significantly expanding its resource base near its Laverton mill and advancing its ASPIRE 400 growth strategy.

Osteopore Limited has drawn down an additional A$500,000 from the first tranche of its redeemable convertible notes, bringing total subscriptions close to the A$5 million tranche limit. The funds will support ongoing operations and future growth initiatives.

3P Learning forecasts steady revenue for FY25 but anticipates a significant 20% uplift in underlying EBITDA and a stronger net cash position, driven by strategic product expansions.

EQ Resources Limited has successfully raised $18.8 million through a share placement, complemented by a $3 million Share Purchase Plan, to fund its tungsten mining projects and reduce debt.

RPM Automotive Group has launched a fully operational tyre recycling plant, boosting its earnings potential while reporting steady revenue and improved profitability for the nine months FYTD.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.